- ASGCT presentation demonstrates lipid nanoparticle (LNP) mediated delivery to the eye in the context of editing of the myocilin (MYOC) gene as a potential treatment for glaucoma - - Expands pipeline ...
Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...
CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia,today announced two upcoming oral presentations highlighting the company’s lead-candidate visugromab at the European Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback